Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share Price Near 52-Week High

Aarey Drugs Share Price is trading at Rs 112.8, down 0.09% today, and remains close to its 52-week high zone with a market capitalisation of Rs 359.86 crore. Aarey Drugs Share Price Today is relevant because the stock is trading near its yearly high even after a mild intraday slip from the open. The latest Univest data confirms the price event, but it does not establish a company-specific catalyst. Aarey Drugs Stock News is therefore centred on the verified price placement, the day’s range and the company’s valuation profile. For readers tracking Aarey Drugs Share Price Live, the key question is not whether the move is dramatic, but how the current level compares with the prior session, the year’s peak zone and the sector benchmark. Univest is covering the move as a near-52-week-high market event.

Aarey Drugs Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 112.8
Previous Close	Rs 112.9
Today's Move	Rs -0.1 (-0.09%)
Open	Rs 116.8
High	Rs 116.8
Low	Rs 112.8
Market Capitalisation	Rs 359.86 crore

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) traded at Rs 112.8 versus the previous close of Rs 112.9, a fall of 0.09%. The stock opened at Rs 116.8, reached a high of Rs 116.8 and touched a low of Rs 112.8.

Aarey Drugs Share Price Today stood at Rs 112.8 against the previous close of Rs 112.9, leaving the stock down Rs 0.1, or 0.09%. The day opened at Rs 116.8, matched the day’s high at Rs 116.8 and touched a low of Rs 112.8, so the price spent the early part of the move above the previous session’s level before easing back to the current quote. Aarey Drugs Share Price therefore moved within a narrow daily range at a level that still sits close to the 52-week high area. Aarey Drugs Share Price News remains focused on the position of the stock near its one-year high rather than on any separate catalyst. In simple terms, the latest Univest price update confirms a near-high setup and points readers toward the valuation picture next.

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 359.86 crore
P/E Ratio	86.17x
P/B Ratio	2.12x
ROE	2.81%
ROCE	5.57%
EPS	Rs 1.31
Book Value Per Share	Rs 53.35
Dividend Yield	0%

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) fundamental metrics show P/E 86.17x, P/B 2.12x, ROE 2.81%, ROCE 5.57%. These figures provide context only and are not a buy or sell signal.

Aarey Drugs & Pharmaceuticals Ltd. has a market capitalisation of Rs 359.86 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 86.17x, P/B at 2.12x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 2.81% and ROCE of 5.57%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.31, book value per share of Rs 53.35, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 12.21x, median ROE of 3.98%, median ROCE of 5.55%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Company P/E Ratio	86.17x
Benchmark Median P/E	12.21x
Benchmark Average P/E	65.39x
Benchmark P/E Range	0x to 3,108.78x
Company P/B Ratio	2.12x
Benchmark Median P/B	1.34x
Company ROE	2.81%
Benchmark Median ROE	3.98%
Company ROCE	5.57%
Benchmark Median ROCE	5.55%
Company Market Capitalisation	Rs 359.86 crore
Benchmark Median Market Cap	Rs 52.86 crore

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) is classified under sector: Trading and industry: Trading.

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 86.17x, which is above the benchmark median of 12.21x, a difference of +605.73%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROE of 2.81%, which is below the benchmark median of 3.98%, a difference of -29.4%. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a ROCE of 5.57%, which is above the benchmark median of 5.55%, a difference of +0.36%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
DIVINE HIRA JEWELLERS LTD	DIVINEHIRA	363.62	51.03	4.69	15.17	16.15
TRUE COLORS LIMITED	TRUECOLORS	355.27	11.4	1.9	25.68	25.65
Tejassvi Aaharam Ltd.	TEJASSVI	354.15	0	8.07	0	-123.61
Veritas (India) Ltd.	VERITAS	366.22	0	0.13	0.71	1.52
Kothari Products Ltd.	KOTHARIPRO	370.06	18.26	0.32	2.95	3.71

Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a P/E ratio of 86.17x compared with the displayed peer median of 11.4x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 2.81% compares with a peer median of 2.95% across the companies shown in the table. ROCE stood at 5.57% versus the displayed peer median of 3.71%, providing a capital-efficiency comparison. Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) has a market capitalisation of Rs 359.86 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Aarey Drugs

• Aarey Drugs Share Price is trading at Rs 112.8 and remains near its 52-week high zone.
• The stock is down 0.09% today, with the previous close at Rs 112.9.
• Aarey Drugs Share Price carries a market capitalisation of Rs 359.86 crore.
• The company’s P/E ratio is 86.17, which is well above the sector median of 12.21.
• ROE is 2.81% and ROCE is 5.57%, giving Aarey Drugs Fundamental Analysis a clear valuation backdrop.

About Aarey Drugs & Pharmaceuticals Ltd.

Aarey Drugs & Pharmaceuticals Ltd. operates in the Trading sector and Trading industry. Aarey Drugs Share Price reflects a company that is being tracked primarily through market capitalisation, valuation ratios and recent price behaviour. The latest quarter revenue reported is Rs 44.63 crore for Jun 2026. In this Aarey Drugs Share News update, the company is discussed through verified market and financial references rather than through unsupported commentary. Univest uses the company’s listed identity, sector classification and reported ratios to place Aarey Drugs Stock News in an organized market context.

Frequently Asked Questions

What is Aarey Drugs Share Price today?

Ans. Aarey Drugs Share Price is Rs 112.8. It is down 0.09% from the previous close of Rs 112.9 and is still trading near its 52-week high zone. The intraday range extended from Rs 112.8 to Rs 116.8.

Why is Aarey Drugs Share Price in the news today?

Ans. Aarey Drugs Share Price is in focus because it is trading near its yearly high. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst.

How far is Aarey Drugs Share Price from its previous close?

Ans. Aarey Drugs Share Price is lower by Rs 0.1 versus the previous close. That difference equals a move of 0.09%, based on the current quote of Rs 112.8.

What is the market capitalisation of Aarey Drugs?

Ans. Aarey Drugs Share Price is backed by a market capitalisation of Rs 359.86 crore. That places the company well above the sector median market cap of Rs 52.86 crore in the same industry set.

How does Aarey Drugs compare with the sector on P/E?

Ans. Aarey Drugs Share Price reflects a P/E of 86.17, which is far above the same-industry median of 12.21 and above the average of 65.39. That makes valuation a central part of the discussion.

What do ROE and ROCE show for Aarey Drugs?

Ans. Aarey Drugs Share Price comes with ROE of 2.81% and ROCE of 5.57%. ROE is below the sector median, while ROCE is roughly in line with the benchmark median of 5.55%.

What does book value mean for Aarey Drugs Share Price?

Ans. Aarey Drugs Share Price has a book value of Rs 53.35 per share. Book value shows the accounting net worth behind each share and helps readers compare price with underlying asset value.

How can investors track Aarey Drugs Share Price on Univest?

Ans. Investors can track Aarey Drugs Share Price on Univest for live price updates, 52-week levels, valuation ratios, company financials and peer comparison. That makes Aarey Drugs Stock News easier to follow in one place.

Track Aarey Drugs Share Price on Univest

Use Aarey Drugs & Pharmaceuticals Ltd. (AAREYDRUGS) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

You can track Aarey Drugs Share Price on Univest for live price movement, 52-week levels, market capitalisation, valuation ratios, recent financial figures and company-specific market insights. Univest also helps readers follow Aarey Drugs Share Price Today alongside sector context, peer comparison and Aarey Drugs Latest News in one place.